Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling

doi:10.4330/wjc.v17.i1.101491

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (578)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

413

Figures (1-3)

Sum=530

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=19

Jan 26, 2025 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Jan 26, 2025; 17(1): 101491
Published online Jan 26, 2025. doi: 10.4330/wjc.v17.i1.101491

Full Size Figure Download Figure

Figure 2 Impacts of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and pulmonary artery remodeling. NO: Nitric oxide; SGLT2i: Sodium-glucose cotransporter-2 inhibitor.

Citation: Zhang JJ, Ye XR, Liu XS, Zhang HL, Qiao Q. Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling. World J Cardiol 2025; 17(1): 101491
URL: https://www.wjgnet.com/1949-8462/full/v17/i1/101491.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i1.101491